TransMedics Group, Inc. (TMDX)
NASDAQ: TMDX · Real-Time Price · USD
72.26
+1.13 (1.59%)
Jul 24, 2026, 4:00 PM EDT - Market closed
TransMedics Group Stock Forecast
Stock Price Forecast
According to 11 analysts polled by S&P Global, TransMedics Group stock has a consensus rating of "Buy" and an average price target of $114. The average 1-year stock price forecast is 57.76% higher than the current stock price, while the lowest is $80 (+10.71%) and the highest is $142 (+96.51%).
Price Target: $114 (+57.76%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for TransMedics Group stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 7 | 7 | 7 | 6 | 6 | 6 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 3 | 2 | 2 | 3 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 12 | 11 | 11 | 11 | 11 | 11 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Buy Maintains $120 | Buy | Maintains | $120 | +66.07% | Jul 22, 2026 |
| William Blair | William Blair | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Jul 22, 2026 |
| TD Cowen | TD Cowen | Buy Maintains $120 | Buy | Maintains | $120 | +66.07% | Jul 11, 2026 |
| Evercore ISI | Evercore ISI | Buy Maintains $100 → $90 | Buy | Maintains | $100 → $90 | +24.55% | Jul 6, 2026 |
| Canaccord Genuity | Canaccord Genuity | Buy Reiterates $124 | Buy | Reiterates | $124 | +71.60% | Jun 30, 2026 |
Financial Forecast
Revenue This Year
732.95M
from 605.49M
Increased by 21.05%
Revenue Next Year
867.80M
from 732.95M
Increased by 18.40%
EPS This Year
1.76
from 2.63
Decreased by -33.08%
EPS Next Year
2.86
from 1.76
Increased by 62.74%
EPS and Forward PE are based on non-GAAP adjusted numbers.